RESUMEN
Polychlorinated biphenyls (PCBs) are a family of 209 congeners listed as Persistent Organic Pollutants in the Stockholm Convention. Although there has been a lot of focus on those congeners present in the Aroclor or Clophen technical mixtures commercialized in the past (legacy PCBs), other industrial processes such as paint and pigment production can generate other congeners as byproducts (Unintentionally Produced PCBs or UP-PCBs). The present study focuses on the analysis of 72 PCB congeners (including 42 UP-PCBs) in the two major rivers surrounding the city of Barcelona -Llobregat and Besós rivers-, and their levels in two wastewater treatment plants during the production of effluents and reclaimed water. It was observed that WWTP can efficiently remove PCBs from untreated water during sludge production where concentrations are six orders of magnitude higher than in water (in the ng g-1 and pg L-1 ranges, respectively). Although PCB levels in the effluent and reclaimed water replenishing the rivers are not negligible, these do not significantly increase the concentrations already found in the studied rivers, and in most cases PCB concentrations in river water are reduced after merging with the reclaimed water due to dilution effect. The presence of UP-PCB-11 (not present in the Aroclor technical mixtures) in the analyzed water and sludge samples is significant (ranging from 22 to 25 % of the total PCB amount in the Besós river), being often one of the most abundant PCB congeners.
RESUMEN
Immunoglobulin-G4-related disease (IgG4-RD) is a chronic immunomediated pathology of different organs of local or systemic nature, which has been established as a separate clinical entity in the early 2000s and is characterized by storiform fibroid inflammation of the affected tissues, their increase, and elevated serum immunoglobulin-G4 (IgG4) levels. The most common manifestations of the disease are major salivary and lacrimal gland enlargement, lymphadenopathy and type 1 autoimmune pancreatitis (AIP1), however, other organs may be also involved (the thyroid, eyes, meninges, heart, lungs, kidneys, aorta, upper airways, mesentery, etc.). The effectiveness of treatment of IgG4-RD, as well as other pathological conditions, is also determined by the timely diagnosis. However, the latter is complicated due to the variety of clinical manifestations and rather variable diagnostic criteria. It is necessary to constantly update the evidence-based knowledge and diagnostic algorithms within this pathology in order to overcome the difficulties, and involve immunologists, endocrinologists, pathologists and specialists in other spheres. This review provides information about the etiology, pathogenesis, and current methods of diagnosis and treatment of IgG4-related diseases, as well as examples of some manifestations of IgG4-RD that an endocrinologist may face in practice.